Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-012792
Filing Date
2023-11-22
Accepted
2023-11-22 10:36:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27546
2 filename2.txt TEXT-EXTRACT 1355
  Complete submission text file 0000000000-23-012792.txt   39964
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filed for) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)